Joyce Lee Net Worth

The estimated Net Worth of Joyce J. Lee is at least $347 Tausend dollars as of 6 February 2013. Ms. Lee owns over 2,000 units of Balchem stock worth over $327,940 and over the last 12 years she sold BCPC stock worth over $0. In addition, she makes $19,000 as Independent Director at Balchem.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Lee BCPC stock SEC Form 4 insiders trading

Joyce has made over 1 trades of the Balchem stock since 2013, according to the Form 4 filled with the SEC. Most recently she bought 2,000 units of BCPC stock worth $52,000 on 6 February 2013.

The largest trade she's ever made was buying 2,000 units of Balchem stock on 6 February 2013 worth over $52,000. On average, Joyce trades about 43 units every 0 days since 2013. As of 6 February 2013 she still owns at least 2,000 units of Balchem stock.

You can see the complete history of Ms. Lee stock trades at the bottom of the page.

Joyce Lee biography

Joyce J. Lee serves as Independent Director of the Company. Since 2016, Ms. Lee has served as the president of North America for Bayer Animal Health. From 2013 to 2015, Ms. Lee was executive Vice President and Area President of Canada and Latin America at Zoetis Inc., a global leader in the discovery, development, manufacture and commercialization of animal health medicines, vaccines and diagnostic products with a focus on both livestock and companion animals. Prior to Zoetis being spun out of Pfizer Inc., Ms. Lee held various senior leadership positions at Pfizer, including serving as Area President of Canada and Latin America and Vice President of Global Poultry Health

What is the salary of Joyce Lee?

As the Independent Director of Balchem, the total compensation of Joyce Lee at Balchem is $19,000. There are 15 executives at Balchem getting paid more, with Theodore Harris having the highest compensation of $3,808,410.

How old is Joyce Lee?

Joyce Lee is 45, she's been the Independent Director of Balchem since 2019. There are 11 older and 1 younger executives at Balchem. The oldest executive at Balchem Corp. is Perry Premdas, 67, who is the Independent Director.

What's Joyce Lee's mailing address?

Joyce's mailing address filed with the SEC is C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE, NJ, 07645.

Insiders trading at Balchem

Over the last 21 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick und David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.

What does Balchem do?

founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

Complete history of Ms. Lee stock trades at Balchem, Zoetis Inc und Elanco Animal Health Inc

Balchem executives and stock owners

Balchem executives and other stock owners filed with the SEC include:

• Theodore Harris,
  Chairman of the Board, President, Chief Executive Officer
• Theodore L. Harris,
  Chairman, CEO & Pres
• Martin Bengtsson,
  Chief Financial Officer
• Scott Mason,
  Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products
• William Backus,
  Chief Accounting Officer
• Mark Stach,
  General Counsel, Secretary
• Carl Martin Bengtsson,
  CFO & Treasurer
• James C. Hyde,
  Sr. VP and GM of Human Nutrition & Health
• Mark A. Stach,
  Gen. Counsel & Corp. Sec.
• John Televantos,
  Lead Independent Director
• Daniel Knutson,
  Independent Director
• Matthew Wineinger,
  Independent Director
• Perry Premdas,
  Independent Director
• David Fischer,
  Independent Director
• Paul Coombs,
  Independent Director
• Joyce Lee,
  Independent Director
• Dino A Rossi,
  President and CEO
• Edward Mcmillan,
  Director
• Matthew David Houston,
  General Counsel, Secretary
• Frank Fitzpatrick,
  Corp Controller & Treasurer
• Mary Theresa Coelho,
  Chief Financial Officer
• Monica Vicente,
  
• Olivier Rigaud,
  
• Elaine R Wedral,
  Director
• Richard Allen Bendure,
  Chief Operating Officer
• Francis X Mcdermott,
  Director
• Paul H Richardson,
  VP Research and Development
• Dana E. Putnam,
  VP and General Manager
• Cruce Patricia Siuta,
  Vice President Technology
• Israel Sheinberg,
  Director
• Winston A Samuels,
  Vice President/GM Encapsulates
• Hoyt Jr Ammidon,
  Director
• Kenneth P Mitchell,
  Director
• Robert T Miniger,
  VP/Human Resources
• David F Ludwig,
  Vice President
• James C Hyde,
  Sr. Vice President
• Kathleen B Fish,
  
• Frederic Boned,
  SVP/GM, Human Nutri. & Health
• Martin Luther Reid,
  SVP Chief Supply Chain Officer
• Hatsuki Miyata,
  EVP, Gen. Counsel & Secretary
• Gunsteren Job Leonard Van,
  SVP and GM, Specialty Products
• Michael Robert Sestrick,
  SVP & Chief Technology Officer
• Michael Brent Tignor,
  SVP & Chief HR Officer
• Jonathan Harrison Griffin,
  SVP & GM, Animal Nutrition